Butterfly Network, Inc.

NYSE:BFLY

Medical - Devices

Healthcare
$6.08 +32.84%

+$1.88 today

Market cap
$1.63B
Beta
2.20
P/E (TTM)
-25.7
EPS (TTM)
-$0.30
52W Low $1.32High $8.01

Volume 4.78M

Average 4.92M

BFLY Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Butterfly Network, Inc.NYSE: BFLY

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q1 FY2026 depreciation & amortization of $1.81M fell 23.3% year over year, ahead of the -25.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 3.2% from the prior quarter. Over 3 fiscal years it compounded at +10.8% a year.

Context

  • Depreciation & amortization amounted to 8.3% of revenue in FY2025, down 4.3 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -23.3% holds above the trailing-twelve-month pace of -25.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.81M+3.2% QoQ
Last fiscal yearDec 2025
$8.08M-21.9% YoY
LTMMar 2026
$7.53M-25.6% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.3%——
1 year-21.9%——
3-year CAGR+10.8%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
8.08M USD
Year-over-year change
-21.9%
4-year CAGR
+40.2%

Depreciation & Amortization vs competitors

How BFLY compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -25.6% is the 7th highest of 9, against a peer median of -4.9%.
  • Depreciation & amortization amounts to 7.3% of revenue for BFLY, versus a peer median of 5.7%.
BFLY Competitors
Depreciation & Amortization for BFLY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMNAMN Healthcare Services, Inc.LTM Mar 2026$152.4M USD-9.9%+4.5%4.5%
OFIXOrthofix Medical Inc.LTM Mar 2026$135.37M USD+42.0%+16.7%16.4%
EVHEvolent Health, Inc.LTM Mar 2026$118.75M USD+4.1%+8.7%6.3%
FLGTFulgent Genetics, Inc.LTM Mar 2026$24.2M USD+0.1%-9.6%7.6%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$17.69M USD-95.7%+207.8%11.1%
SIBNSI-BONE, Inc.LTM Mar 2026$8.15M USD+78.5%-7.6%4.0%
BFLYButterfly Network, Inc.LTM Mar 2026$7.53M USD-25.6%+10.8%7.3%
VALNValneva SELTM Mar 2026€6.46M EUR-64.9%+1.1%4.1%
ARVNArvinas, Inc.LTM Mar 2026$4.5M USD-21.1%-14.1%5.0%
Peer median (excluding BFLY) —-4.9%+2.8%5.7%

Competitors are the stored peer set for BFLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue62.57M73.39M65.9M82.06M97.61M
Cost of Revenue45.51M33.93M49.04M33.23M51.88M
Gross Profit17.05M39.46M16.86M48.83M45.73M
Gross Margin27.3%53.8%25.6%59.5%46.9%
Research & Development74.46M88.04M55.62M37.8M36.26M
Selling, General & Admin135.32M144.44M106.85M85.44M85.11M
Operating Expenses209.78M232.48M162.47M123.24M132.15M
Depreciation & Amortization2.09M5.94M10.57M10.34M8.08M
EBITDA(29.55M)(162.74M)(123.04M)(60.92M)(67.38M)
EBITDA Margin-47.2%-221.8%-186.7%-74.2%-69.0%
Operating Income(192.73M)(193.02M)(145.61M)(74.41M)(86.42M)
Operating Margin-308.0%-263.0%-221.0%-90.7%-88.5%
Interest Income2.57M3.38M7.45M5.02M5.91M
Interest Expense651K2K01.26M1.49M
Other Income / Expenses160.44M24.34M11.99M1.89M9.46M
Income Before Tax(32.29M)(168.68M)(133.62M)(72.52M)(76.95M)
Pre-Tax Margin-51.6%-229.8%-202.8%-88.4%-78.8%
Income Tax Expense121K42K82K(32K)110K
Net Income(32.41M)(168.72M)(133.7M)(72.49M)(77.06M)
Net Margin-51.8%-229.9%-202.9%-88.3%-79.0%
EPS (Basic)(0.19)(0.84)(0.65)(0.34)(0.31)
EPS (Diluted)(0.19)(0.84)(0.65)(0.34)(0.31)
Weighted Avg Shares173.81M199.85M205.39M211.68M247.12M
Weighted Avg Shares (Diluted)173.81M199.85M205.39M211.68M247.12M

Butterfly Network, Inc.

NYSE:BFLY

Intrinsic Alpha fair value

Locked

Current Price

$6.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.